We found out last Monday evening that the Colorado legislature is ramming through a package of three radical pro-abortion bills: SB23-188, SB23-189, and SB23-190.
The most dangerous and impacting to pregnancy resource centers is SB23-190: Deceptive Trade Practice Pregnancy-related Service. The language of this bill could penalize pregnancy centers for trying to advertise their services to help pregnant women in crisis. Even more devastating is a clear ban on any means of offering anything intending to reverse an abortion pill.
Chelsea and I spent this last week engaged in this battle. Tuesday evening we working on Chelsea’s testimony for the judiciary committee on Wednesday. Thursday and Friday we worked on information to send out to legislators about this bill.
In this episode we play Chelsea’s testimony in the bill committee. We also play some salient points from other testimonies. In particular, we respond to some of the testimony of Dr. Mitchell Creinin, who conducted the world-renowned “inconclusive” clinical trial on abortion pill reversal. Dr. Creinin concludes that the practice is unproven and “medical fraud.”
We also played clips from other medical professionals who disputed Dr. Creinin’s claims.
If you are listening to this episode the day it is released, March 19, 2023, the bill is at the Colorado Senate floor and will voted on today. Prayers for this situation are very much appreciated.
Update: Senate floor debate for these bills has been moved to the next day, Tuesday, March 21.
Colorado Senate Judiciary [March 15, 2023 – Upon Adjournment] [Recording]
Delgado G, Condly SJ, Davenport M, Tinnakornsrisuphap T, Mack J, Khauv V, Zhou PS. A case series detailing the successful reversal of the effects of mifepristone using progesterone. Issues Law Med. 2018 Spring;33(1):21-31. PMID: 30831017. [Full study PDF]
Creinin MD, Hou MY, Dalton L, Steward R, Chen MJ. Mifepristone Antagonization With Progesterone to Prevent Medical Abortion: A Randomized Controlled Trial. Obstet Gynecol. 2020 Jan;135(1):158-165. doi: 10.1097/AOG.0000000000003620. PMID: 31809439. [Full study PDF]
Wahabi HA, Fayed AA, Esmaeil SA, Bahkali KH. Progestogen for treating threatened miscarriage. Cochrane Database Syst Rev. 2018 Aug 6;8(8):CD005943. doi: 10.1002/14651858.CD005943.pub5. PMID: 30081430; PMCID: PMC6513446. [Full study PDF]
Kooistra B, Dijkman B, Einhorn TA, Bhandari M. How to design a good case series. J Bone Joint Surg Am. 2009 May;91 Suppl 3:21-6. doi: 10.2106/JBJS.H.01573. PMID: 19411496.
Dalziel K, Round A, Stein K, Garside R, Castelnuovo E, Payne L. Do the findings of case series studies vary significantly according to methodological characteristics? Health Technol Assess. 2005 Jan;9(2):iii-iv, 1-146. doi: 10.3310/hta9020. PMID: 15588556.
Abortion Pill Reversal Helpline